Trial Profile
An Open-Label, Randomized Study to Evaluate the Radiographic Efficacy and Safety of Enbrel (Etanercept) added to Methotrexate in Comparison with Usual Treatment in Subjects with Moderate Rheumatoid Arthritis Disease Activity
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 06 Oct 2021
Price :
$35
*
At a glance
- Drugs Etanercept (Primary) ; Ciclosporin; Gold; Hydroxychloroquine; Leflunomide; Methotrexate; Methotrexate; Methotrexate; Sulfasalazine
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms EXTRA
- Sponsors Pfizer; Wyeth
- 05 Oct 2021 This trial has been completed in Spain and France (End Date: 27 Jan 2010), according to European Clinical Trials Database record.
- 10 Mar 2012 The trial status is recruiting in (Spain, France, United Kingdom), completed in (Denmark) as reported by European Clinical Trials Database.
- 20 Jun 2011 Status changed from completed to discontinued as reported by ClinicalTrials.gov.